Ki67 Labelling Index predicts clinical outcome and survival in oral squamous cell carcinoma
Open Access
- 1 January 2021
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Journal of Applied Oral Science
- Vol. 29, e20200751
Abstract
Objective To investigate the Ki 67 expression and its correlation with clinicopathological features and 3 years as well as 5 years survival rate in oral squamous cell carcinoma (OSCC). Methodology Total 217cases of OSCC primarily treated with surgery with or without radiation were included. All patients were followed up for 3 years and 150 were followed up of 5 years for disease free survival. The immunohistochemistry was carried out on neutral buffered formalin fixed paraffin embedded tissue to evaluate the expression of Ki67. Results The Ki67 labeling index (LI) was significantly higher with respect to adverse clinicopathological parameters such as histopathological grading (p<0.001), clinical TNM staging (p<0.001) and nodal metastasis (p<0.001). The OSCC patients survived for less than 3 and 5 years were showed significantly higher Ki67 LI as compared to diseases free survived more than 3 and 5 years(p<0.001). The three years survival rate of OSCC patient significantly higher with low Ki67 LI (≤45) 96.2%, followed by moderate Ki67 LI (46 to 60) 60.7% and high Ki67 LI (≥61) 37.7% (p<0.001). The five years survival rate of OSCC patient statistically significantly higher with low Ki67 LI (≤45)93.3%, followed by moderate Ki67 LI (46 to 60) 46.8% and Ki67 LI (≥61) 23.3% (p<0.001). Conclusion The measurement of cell proliferative activity by using Ki67 antigen expression in individual OSCC might provide unique, predictive information on clinical outcome, prognosis and deciding treatment modalities in OSCC.Keywords
This publication has 36 references indexed in Scilit:
- Predictive value of high Ki‐67 expression in stage I oral squamous cell carcinoma specimens after primary surgeryHead & Neck, 2011
- Actual proliferating index in oral squamous cell carcinoma and leukoplakiaJournal of Investigative and Clinical Dentistry, 2011
- High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomasOral Oncology, 2009
- Correlation of proliferative markers (Ki-67 and PCNA) with survival and lymph node metastasis in oral squamous cell carcinoma: a clinical and histopathological analysis of 113 patientsInternational Journal of Oral and Maxillofacial Surgery, 2006
- Common markers of proliferationNature Reviews Cancer, 2006
- Predictive factors of occult metastasis and prognosis of clinical stages I and II squamous cell carcinoma of the tongue and floor of the mouthOral Oncology, 2004
- Prognostic Relevance of Ki-67 Antigen Expression in 329 Cases of Oral Squamous Cell CarcinomaORL, 2002
- Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the oral cavity: clinicopathological and prognostic significanceOral Oncology, 2002
- Ki67 protein: the immaculate deception?Histopathology, 2002
- Predicting tumor metastasis in patients with oral cancer by means of the proliferation marker Ki67.Journal of Oral Science, 1999